Singapore Scientists Develop Treatment Targeting Cancer-Fuelling Fluid

In short

• Singapore scientists are developing a treatment to target a fluid that fuels cancer in the abdominal lining.
• The team is confident the first phase of a human clinical trial will start in five years.
• The treatment is still in development and has not yet been tested in people.

Why the Good News Desk likes this one

The treatment targets fluid that helps cancer grow in the abdominal lining. The work is still at an early stage. The first human trial is expected in about five years, so patients will not see it soon.

Ask this story

Answers come only from the material behind this story, with a link to the source.